Bids Are Invited For Opening Of The Process Aiming At The Acquisition Of Cancer Medicines Of The State Health Network Of Sergipe

Recomplinant Human Alfaepoetine - Concentration/Dosage 40,000 Iu/Ml, Formaformatic Injectable Solution, 1Ml Vial Presentation, Intravenous Or Subcutaneous Administration Road, Cetuximab - Concentration/Dosage 100 Mg/Ml, Pharmaceutical Form Injectable Solution Intravenous Administration, Cisplatin - Concentration/Dosage 1Mg/Ml With 10Ml, Cisplatin - Concentration/Dosage 1Mg/Ml With 50Ml, 07/02/2025, Cladribin - Concentration/Dosage 1 Mg/Ml, Dacarbazine - Dacarbazin Concentration/Dosage 100 Mg, Pharmaceutical Form Poisted For Injectable Solution, Epirubicin, Hydrochloride - Concentration/Dosage 10 Mg, Polyophilized Pharmaceutical Form For Injectable Solution, Viade Intravenous Or Intravesical Administration, Fluoruracilla - Concentration/Dosage 50Mg/Ml, 10Ml Ampoule Flask, Yarrubicin, Hydrochloride - 10 Mg, Ampoule Flask, Powder, Injectable Solution, Human Immunoglobulin - Antithylit. Concentration/Dosage 25Mg, Pharmaceutical Form With Injectable Solution, Form Of Presentation Ampoule Flask, As Set In The Product Registration, Pemetrexede - Concentration/Dosage 100 Mg, Pemetrexede - Concentration/Dosage 500 Mg, Vinorelbine - 50 Mg (10Mg/Ml In 5Ml)